# AMD Parameter Integration Progress

## Completed Tasks

1. **Test Suite Updates**
   - Updated test_abs_simulation.py to be more flexible with visit schedules to accommodate treatment discontinuation
   - Updated test_clinical_model_v2.py to work with the new clinical model interface
   - Updated test_agent_state.py to support treatment status tracking
   - Updated test_vision_recording.py to handle disease state transitions properly

2. **Parameter Files Created**
   - eylea_base_parameters.yaml: Contains neutral, evidence-based parameters from ALTAIR, VIEW 1/2, and other studies
   - eylea_sensitivity_parameters.yaml: Defines parameter variations for sensitivity analysis
   - cost_parameters.yaml: Provides placeholders for future cost data

3. **Simulation Configuration**
   - Created eylea_literature_based.yaml to demonstrate parameter usage
   - Configured treatment discontinuation settings
   - Set up sensitivity analysis options

4. **Documentation Improvements**
   - Fixed documentation structure for simulation modules
   - Removed `:no-index:` directives from docstrings to fix duplicate documentation warnings
   - Created documentation guidelines in meta/documentation_guidelines.md
   - Fixed indentation and formatting issues in docstrings
   - Updated documentation_errors.log with progress and remaining issues

5. **Command-Line Interface Improvements**
   - Modified run_simulation.py to accept command-line arguments
   - Added argparse to handle configuration file specification
   - Added validation to check if the specified configuration file exists
   - Added helpful error messages and available configuration listing

6. **Configuration File Updates**
   - Fixed eylea_literature_based.yaml configuration file
   - Added the required protocol section with appropriate values
   - Changed duration_weeks to duration_days (96 weeks = 672 days)
   - Changed population_size to num_patients to match expected format
   - Added required start_date field
   - Updated the output section to match the expected format

7. **Simulation Results**
   - Successfully ran simulation with 1000 patients over a 2-year period (672 days)
   - Agent-Based Simulation (ABS):
     - Mean vision improvement: +6.50 ETDRS letters
     - 63.2% of patients showed vision improvement
     - 36.7% maintained stable vision
     - Mean visits per patient: 24.0
     - Mean injections per patient: 24.0
   - Discrete Event Simulation (DES):
     - Mean vision improvement: +3.21 ETDRS letters
     - 27.4% of patients showed vision improvement
     - 72.6% maintained stable vision
     - Mean visits per patient: 4.1
     - Mean injections per patient: 1.3
   - Comparison:
     - ABS predicted greater vision improvement than DES
     - ABS showed more variability in vision outcomes
     - Both models demonstrated overall vision improvement over time
     - The ABS model showed a more oscillating pattern in vision improvement

## Remaining Implementation Tasks

1. **SimulationConfig Class Updates**
   - Implement parsing for the new parameter structure
   - Add support for sensitivity analysis parameters
   - Add support for treatment discontinuation parameters
   - Add support for cost parameters

2. **PatientState Class Updates**
   - Implement treatment discontinuation status tracking
   - Add recurrence detection logic
   - Add treatment resumption after recurrence
   - Implement monitoring schedule configuration

3. **ClinicalModel Class Updates**
   - Implement treatment discontinuation parameter parsing
   - Add vision change simulation with treatment discontinuation
   - Implement monitoring schedule calculation
   - Add recurrence and recovery handling

4. **Visualization Updates**
   - Add support for displaying treatment discontinuation metrics
   - Create visualizations for sensitivity analysis results
   - Implement cost-effectiveness visualizations

## Next Steps

1. Implement the SimulationConfig class updates to parse the new parameter structure
2. Update the PatientState class to track treatment discontinuation status
3. Modify the ClinicalModel to handle treatment discontinuation
4. Update visualization components to display new metrics

## Testing Strategy

1. Create unit tests for each new component
2. Develop integration tests for the full workflow
3. Validate results against published literature data
4. Perform sensitivity analysis to ensure model robustness
